---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-021310"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2024-05-08T23:59:59+00:00"
generated_at: "2026-06-02T09:22:54.738219+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "low"
source: SEC EDGAR
---

# Aquestive Therapeutics posts Q1 2024 earnings supplemental materials; no financial data provided in filing excerpt

## Summary
- Furnished investor presentation for Q1 2024 earnings results on May 7, 2024.
- Presentation available on company website; content not fully reproduced in the filing.
- No specific revenue, EPS, or guidance figures visible in the provided excerpt.
- Item 7.01 disclosure with Exhibit 99.1; deemed furnished, not filed.
- Company trades on Nasdaq under ticker AQST.

## SEC filing metadata
- accession: 0001628280-24-021310
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2024-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000162828024021310/0001628280-24-021310-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000162828024021310/aqst-20240507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-021310
- JSON: https://secwatch.observer/filing/0001628280-24-021310.json
- Plain text: https://secwatch.observer/filing/0001628280-24-021310.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.